Results for novartis: 61

Novartis announced that the US Department of Health and Human Services, Biomedical Advanced Research and Development Authority (HHS, BARDA) has awarded Novartis Vaccines a contract for ...

Novartis has strengthened its vaccines pipeline through an exclusive agreement to license AlphaVax' investigational Cytomegalovirus (CMV) vaccine program. This CMV agreement adds to Novartis' promising ...

PHARMACEUTICAL giant Novartis AG said yesterday it will buy the pulmonary drug unit of California-based Nektar Therapeutics for US$115 million ...

Novartis AG, the world's third-largest pharmaceutical company, said yesterday that it has reached an agreement with Zhejiang Tianyuan Bio-Pharmaceutical, one of the largest private makers of influenza vaccines in China, to buy an 85% stake in the Chinese firm.The Swiss company did not disclose any...

* Vanda's shares rise 7.3 percent after Novartis deal * Novartis to pay Vanda $200 mln for U.S. rights to Fanapt BOSTON, Oct 13 - Shares of Vanda Pharmaceuticals Inc rose 7.3 percent on Tuesday...

WASHINGTON, Sept 10 - The New England Journal of Medicine published data on Thursday supporting reports that an H1N1 swine flu vaccine being made by Novartis <NOVN.VX> can protect people with a single dose. Novartis...

* FTSEurofirst 300 index up 0.1 percent * Novartis gains as produces flu drug * Banks reverse early losses LONDON, June 12 - European shares rose on Friday morning as positive data from China helped...

* All doses of QAB149 met main target in late stage trials * Showed significant improvement over two approved medicines * Development head says could be a billion-dollar seller ZURICH, May 21 - Novartis AG's...

Novartis recently brought 'diabetes to light' when it united with the International Diabetes Federation (IDF) by lighting its India headquarters at Worli in blue on World Diabetes Day...

WASHINGTON, Dec 19 - U.S. health regulators have approved Novartis' drug Gleevac to reduce the risk of cancer recurring in patients with a rare type of stomach cancer, Novartis said on Friday. Gleevac is already...